Vimarsana
Biggest News Aggregation in the World

Page 26 - Testing Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Testing Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Testing Solutions Today - Breaking & Trending Today

Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response - Vimarsana News

Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response

calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians and public health leaders a standard tool to measure antibody response to SARS-CoV-2 RARITAN, N.J., May 21, 2021 /CNW/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the launch of the first quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test. Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocaps...

Pen Testing As A Service (PTaaS): What It Is And What It Should Do - Vimarsana News

Pen Testing As A Service (PTaaS): What It Is And What It Should Do

PTaaS automates part of the pen testing process and assigns pen testing programs to cloud-based software that can be customized.

Source: forbes.com
FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System - Vimarsana News

FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System

CALGARY, AB, May 10, 2021 /PRNewswire/ -  FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary "FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces the next phase of its ongoing clinical trials with its trial partner Toolbox Medical Innovations ("Toolbox"). The Company is pleased to report that approximately 600 volunteer participants, including both symptomatic and asymptomatic individuals, are being identified from six clinical site locations across Califor...

MRIGlobal to Provide COVID-19 Testing Solutions to Department of Homeland Security - Vimarsana News

MRIGlobal to Provide COVID-19 Testing Solutions to Department of Homeland Security

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
MRIGlobal to Provide COVID-19 Testing Solutions to Department of Homeland Security - Vimarsana News

MRIGlobal to Provide COVID-19 Testing Solutions to Department of Homeland Security

Share this article Share this article KANSAS CITY, Mo., May 5, 2021 /PRNewswire/ -- The Department of Homeland Security (DHS) has selected MRIGlobal as an awardee of their COVID-19 Testing Solutions Indefinite Delivery/Indefinite Quantity (IDIQ) multiple award contract. The COVID-19 Testing Solutions contract will support DHS throughout the department and its components. MRIGlobal's award includes the Managed Testing Services and the Molecular Diagnostic Test Kits and Testing Services 1 scope of work. DHS awarded four contracts, which have a one year base and four one year option periods, wit...